Overview
TELA market data
Price History
TELA price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.83 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.36 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.50 – $2.14 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $31.8 · P/B 8.32 · P/S 0.39.
Company News
8-K filing — TELA Bio, Inc. (TELA)SEC EDGAR · Jun 11, 2026, 8:05 PM
TELA Bio Q1 2026 Earnings Call TranscriptBenzinga · May 12, 2026, 9:35 PM
TELA Bio FY2026 Revenue expected to be more than $86.697M vs $86.849M EstBenzinga · May 12, 2026, 8:10 PM